Consort Medical logo

CSRT - Consort Medical Share Price

1040p 314.0  43.3%

Last Trade - 18/11/19

Sector
Healthcare
Size
Mid Cap
Market Cap £358.4m
Enterprise Value £455.8m
Revenue £305.1m
Position in Universe 634th / 1845
Bullish
Bearish
Unlock CSRT Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CSRT Revenue Unlock CSRT Revenue

Net Income

CSRT Net Income Unlock CSRT Revenue

Normalised EPS

CSRT Normalised EPS Unlock CSRT Revenue

PE Ratio Range

CSRT PE Ratio Range Unlock CSRT Revenue

Dividend Yield Range

CSRT Dividend Yield Range Unlock CSRT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CSRT EPS Forecasts Unlock CSRT Revenue
Profile Summary

Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company's principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak's core business is the manufacture of inhaled drug delivery devices for life sciences partners and its operations are based in the United Kingdom. The Aesica business manufactures and sells active pharmaceutical ingredients (API), formulated pharmaceutical products and packaging services to the pharmaceutical industry and its operations are based in the United Kingdom and Europe. It offers its services to customers, such as pharmaceutical companies and life sciences. Its device products include metered dose inhalers, dry powder devices, actuators, dose counters, disposable auto-injectors, nasal devices and point-of-care diagnostics devices.

Directors
Last Annual April 30th, 2019
Last Interim April 30th, 2019
Incorporated March 22, 1946
Public Since January 8, 1986
No. of Shareholders: n/a
No. of Employees: 1,956
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE All Share , FTSE All Share Health Care , FTSE All Share Health Care Equipment & Services , FTSE Smallcap , FTSE Smallcap Ex Its , FTSE Techmark Focus , FTSE Techmark All Share , ,
Exchange London Stock Exchange (Full)
Shares in Issue 49,362,234
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CSRT Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CSRT
Upcoming Events for CSRT
Similar to CSRT
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.